Rossari Biotech
Ticker > Company >

Rossari Biotech share price

Rossari Biotech Ltd.

NSE: ROSSARI BSE: 543213 SECTOR: Chemicals  1.42 L   742   130

683.90
+3.75 (0.55%)
BSE: Today, 11:13 AM

Price Summary

Today's High

₹ 694.1

Today's Low

₹ 680

52 Week High

₹ 966

52 Week Low

₹ 568.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3786.52 Cr.

Enterprise Value

₹ 3800.65 Cr.

No. of Shares

5.54 Cr.

P/E

33

P/B

3.52

Face Value

₹ 2

Div. Yield

0.07 %

Book Value (TTM)

₹  194.13

CASH

₹ 16.02 Cr.

DEBT

₹ 30.14 Cr.

Promoter Holding

68.18 %

EPS (TTM)

₹  20.72

Sales Growth

19.01%

ROE

11.3 %

ROCE

15.48%

Profit Growth

15.15 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year19.01%
3 Year10.09%
5 Year18.99%

Profit Growth

1 Year15.15%
3 Year13.02%
5 Year11.86%

ROE%

1 Year11.3%
3 Year10.34%
5 Year13.51%

ROCE %

1 Year15.48%
3 Year14.02%
5 Year17.86%

Debt/Equity

0.028

Price to Cash Flow

41.07

Interest Cover Ratio

17.1418

CFO/PAT (5 Yr. Avg.)

0.819755914779466

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 68.18 0.00
Dec 2024 68.19 0.00
Sep 2024 68.27 0.00
Jun 2024 68.32 0.00
Mar 2024 68.32 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 24.902 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 17.1418.
  • The company has an efficient Cash Conversion Cycle of 38.7064 days.
  • The company has a high promoter holding of 68.18%.

 Limitations

  • The company has shown a poor revenue growth of 10.0941183849238% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 313.8 300.71 335.99 368.28 426.65
Total Expenditure 272.08 260.9 291.72 318.32 374.45
Operating Profit 41.72 39.8 44.27 49.96 52.2
Other Income 1.34 1.26 1.08 1.01 2.4
Interest 1.74 2.33 1.9 2.28 3.08
Depreciation 6.58 6.06 6.54 7.43 7.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 34.75 32.67 36.91 41.26 43.86
Tax 8.58 8.34 9.49 10.63 11.49
Profit After Tax 26.17 24.33 27.42 30.63 32.36
Adjusted EPS (Rs) 4.74 4.4 4.96 5.53 5.85

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 690.41 1072.84 975.17 1202.91 1431.63
Total Expenditure 569.56 953.12 855.07 1045.88 1254.02
Operating Profit 120.86 119.72 120.11 157.03 177.61
Other Income 10.21 15.77 6.14 11 14.37
Interest 2.99 2.55 4.62 9.7 9.58
Depreciation 22.07 26.27 25.98 24.19 27.69
Exceptional Items 0 0 0 0 0
Profit Before Tax 106 106.68 95.65 134.13 154.7
Tax 26.9 27.21 24.26 34.49 39.96
Net Profit 79.1 79.47 71.39 99.65 114.74
Adjusted EPS (Rs.) 15.23 14.44 12.94 18.04 20.72

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 10.39 11.01 11.03 11.05 11.07
Total Reserves 394.06 773.51 847.67 949.29 1066.1
Borrowings 0 0 34.93 24.94 0
Other N/C liabilities 57.68 56.95 55.78 65.19 69.56
Current liabilities 165.62 191.08 306.29 394.54 505
Total Liabilities 627.75 1032.55 1255.7 1445.02 1651.73
Assets
Net Block 170.75 177.38 157.06 167.29 179.2
Capital WIP 0.32 0.84 10.67 24.6 34.09
Intangible WIP 0 0 3.01 0 0
Investments 9.25 371.85 472.78 490.6 493.11
Loans & Advances 61.57 63.41 65.28 83.12 96.45
Other N/C Assets 19.65 0.1 1.27 1.23 1.25
Current Assets 366.21 418.97 545.63 678.18 847.64
Total Assets 627.75 1032.55 1255.7 1445.02 1651.73
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 106 106.68 95.65 134.13 154.7
Adjustment 18.41 22.65 30.39 30.36 33.72
Changes in Assets & Liabilities -41.39 -71.99 11.92 -55.08 -56.94
Tax Paid -30.93 -24.23 -25.01 -35.5 -39.28
Operating Cash Flow 52.09 33.12 112.94 73.92 92.2
Investing Cash Flow -37 -318.12 -160.39 -69.78 -69.57
Financing Cash Flow -29.45 296.91 61.21 -22.09 -32.27
Net Cash Flow -14.36 11.91 13.76 -17.95 -9.64

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 68.32 68.32 68.27 68.19 68.18
anita menezes 1.81 1.81 1.81 1.81 1.81
chari family trust - in t... 0.20 0.20 - - 0.20
edward menezes 29.18 29.18 29.15 29.12 29.11
jyotishna sunil chari 1.81 1.81 1.81 1.81 1.81
menezes family trust - in... 0.20 0.20 - - 0.20
mikhail menezes 0.24 0.24 0.24 0.24 0.24
rossari biotech (india) p... - - 5.46 5.45 5.45
sunil srinivasan chari 29.12 29.12 29.10 29.07 29.06
yash sunil chari 0.30 0.30 0.30 0.30 0.30
chari family trust - in t... - - 0.20 0.20 -
menezes family trust - in... - - 0.20 0.20 -
rossari biotech (india) p... - 5.46 - - -
rossari biotech india pvt... 5.46 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 31.68 31.68 31.73 31.81 31.82
canara robeco mutual fund... 1.93 1.93 1.93 1.93 1.93
life insurance corporatio... 3.07 3.74 4.01 4.01 4.01
llp 0.01 0.02 0.03 0.03 0.04
motilal oswal small cap f... 1.06 1.20 1.60 1.68 2.04
sbi small cap fund 5.72 5.28 5.28 5.27 5.27
uti-flexi cap fund - - - - 4.06
uti flexi cap fund 4.57 4.55 4.38 4.37 -
uti india dynamic equity ... 1.16 1.16 1.10 1.02 -
icici lombard general ins... 1.32 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research Nuvama Wealth
Research Report By:
Research Edelweiss
Research Edelweiss
Research Nuvama Wealth
Research Nuvama Wealth
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q4FY21
Concall Q3FY24
Concall Q3FY22
Concall Q3FY21
Concall Q2FY24
Concall Q2FY21
Concall Q1FY25
Concall Q1FY24
Concall Q1FY23
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY20
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY22
Presentation Q1FY21

Company News

Rossari Biotech gets nod for capacity expansion 28 Apr, 10:29 AM Rossari Biotech - Quaterly Results 25 Apr, 8:38 PM Rossari Biotech - Quaterly Results 25 Apr, 8:38 PM Rossari Biotech informs about disclosure 20 Feb, 2:35 PM Rossari Biotech - Quaterly Results 21 Jan, 7:09 PM Rossari Biotech - Quaterly Results 21 Jan, 7:09 PM Rossari Biotech incorporates wholly-owned subsidiary 26 Dec, 4:00 PM Rossari Biotech informs about updates on acquisition 11 Dec, 3:21 PM Rossari Biotech - Quaterly Results 19 Oct, 3:21 PM Rossari Biotech - Quaterly Results 19 Oct, 3:21 PM Rossari Biotech - Quaterly Results 19 Oct, 3:21 PM Rossari Biotech’s arm incorporates step down wholly owned subsidiary 9 Oct, 12:30 PM Rossari Biotech informs about investor meet 12 Sep, 4:06 PM Rossari Biotech reports 19% rise in Q1 consolidated net profit 22 Jul, 2:14 PM Rossari Biotech - Quaterly Results 20 Jul, 7:33 PM Rossari Biotech informs about disclosure 20 Jul, 11:50 AM Rossari Biotech - Quaterly Results 29 Apr, 7:26 PM Rossari Biotech - Quaterly Results 29 Apr, 7:26 PM Rossari Biotech informs about newspaper publication 22 Jan, 12:52 PM Rossari Biotech - Quaterly Results 20 Jan, 5:56 PM Rossari Biotech - Quaterly Results 20 Jan, 5:56 PM Rossari Biotech informs about Board Meeting 13 Jan, 10:50 AM Rossari Biotech - Quaterly Results 21 Oct, 3:02 PM Rossari Biotech - Quaterly Results 21 Oct, 3:02 PM Rossari Biotech - Quaterly Results 21 Oct, 3:02 PM Rossari Biotech informs about analyst meeting 16 Oct, 5:02 PM Rossari Biotech informs about board meeting 14 Oct, 10:57 AM Rossari Biotech incorporates wholly-owned Subsidiary in Bangladesh 14 Aug, 10:30 AM Rossari Biotech - Quaterly Results 29 Jul, 2:40 PM Rossari Biotech - Quaterly Results 29 Jul, 2:40 PM Rossari Biotech - Quaterly Results 29 Jul, 2:40 PM Rossari Biotech informs about conference call 1 Jun, 10:54 AM Rossari Biotech informs about newspaper publication 9 May, 1:23 PM Rossari Biotech - Quaterly Results 29 Apr, 4:52 PM Rossari Biotech - Quaterly Results 29 Apr, 4:52 PM Rossari Biotech - Quaterly Results 29 Apr, 4:52 PM Rossari Biotech acquires balance 16% stake in Tristar Intermediates 13 Apr, 9:20 AM Rossari Biotech informs about closure of trading window 27 Mar, 5:03 PM Rossari Biotech - Quaterly Results 4 Feb, 2:55 PM Rossari Biotech - Quaterly Results 4 Feb, 2:55 PM Rossari Biotech - Quaterly Results 4 Feb, 2:55 PM Rossari Biotech informs about compliance certificate 7 Jan, 11:35 AM Rossari Biotech informs about disclosure of related party transactions 19 Nov, 11:56 AM Rossari Biotech - Quaterly Results 5 Nov, 2:35 PM Rossari Biotech - Quaterly Results 5 Nov, 2:35 PM Rossari Biotech - Quaterly Results 5 Nov, 2:35 PM Rossari Biotech gets nod to incorporate wholly owned subsidiary in Bangladesh 20 Oct, 10:19 AM Rossari Biotech informs about newspaper publication 8 Aug, 4:46 PM Rossari Biotech - Quaterly Results 6 Aug, 4:03 PM Rossari Biotech - Quaterly Results 6 Aug, 4:03 PM

Rossari Biotech Stock Price Analysis and Quick Research Report. Is Rossari Biotech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Rossari Biotech stock price today is Rs 684.95. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Rossari Biotech . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Rossari Biotech has a PE ratio of 33.0510519204787 which is high and comparatively overvalued .

  • Share Price: - The current share price of Rossari Biotech is Rs 684.95. One can use valuation calculators of ticker to know if Rossari Biotech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Rossari Biotech has ROA of 7.4105 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Rossari Biotech has a Current ratio of 1.6785 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Rossari Biotech has a ROE of 11.2964 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Rossari Biotech has a Debt to Equity ratio of 0.028 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Rossari Biotech has reported revenue growth of 19.0137 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Rossari Biotech for the current financial year is 12.4061557890737 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Rossari Biotech is Rs 0.5 and the yield is 0.0731 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Rossari Biotech is Rs 20.724 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Rossari Biotech in Ticker for free. Also, one can get the intrinsic value of Rossari Biotech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Rossari Biotech

Rossari Biotech Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Rossari Biotech Ltd. is a leading specialty chemicals company that focuses on providing customized solutions for various industrial and consumer applications. With a diverse product portfolio and a strong emphasis on research and development, the company has established itself as a prominent player in the specialty chemicals industry.

Rossari Biotech Ltd. - Share Price

The share price of Rossari Biotech Ltd. reflects the market's perception of the company's performance and prospects. It is influenced by various factors such as financial results, industry trends, market sentiment, and overall economic conditions. Investors can track the share price on our website using our pre-built screening tool.

Rossari Biotech Ltd. - Balance Sheet

The balance sheet provides a snapshot of Rossari Biotech Ltd.'s financial position at a given point in time. It shows the company's assets, liabilities, and shareholders' equity. Our website provides the annual reports for Rossari Biotech Ltd., which contain the balance sheet and other financial statements. Additionally, our premium features allow investors to perform fair value calculations using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Rossari Biotech Ltd. - Annual Report

The annual report of Rossari Biotech Ltd. provides a comprehensive overview of the company's performance during the year. It includes a detailed analysis of financial results, operational highlights, business strategy, and risk factors. Investors can download the annual report from our website to gain insights into the company's progress and future prospects.

Rossari Biotech Ltd. - Dividend

Dividends are one of the ways through which companies distribute profits to their shareholders. Rossari Biotech Ltd. has a consistent track record of paying dividends to its shareholders. Investors can find information about dividends in the annual reports and other financial statements available for download on our website.

Rossari Biotech Ltd. - Quarterly Result

The quarterly results of Rossari Biotech Ltd. provide an update on the company's financial performance and operational metrics for a particular quarter. Investors can analyze these results to assess the company's progress towards its strategic goals. Our website provides quarterly results and other financial statements for Rossari Biotech Ltd., which can be used to track the company's performance.

Rossari Biotech Ltd. - Stock Price

The stock price of Rossari Biotech Ltd. is influenced by various factors, including market conditions, industry trends, and company-specific factors. Investors can view the historical stock price data and track the performance of Rossari Biotech Ltd. on our website. Our pre-built screening tools can help investors evaluate the company's stock price movement and identify potential investment opportunities.

Rossari Biotech Ltd. - Price Chart

The price chart for Rossari Biotech Ltd. visually represents the historical movement of the company's stock price over a specific time period. It helps investors identify trends, patterns, and potential support or resistance levels. Our website provides price charts that can be customized to display different time frames and technical indicators.

Rossari Biotech Ltd. - News

Our website provides the latest news and updates about Rossari Biotech Ltd. Investors can stay informed about important developments, such as new product launches, collaborations, acquisitions, and regulatory approvals. Access to timely and reliable news is essential for long-term stock investors looking for stock analysis.

Rossari Biotech Ltd. - Concall Transcripts

Concall transcripts provide a detailed record of the discussions and presentations made during the company's conference calls with analysts and investors. These transcripts contain valuable insights into the company's strategy, performance, and future plans. Investors can download the concall transcripts from our website to gain a better understanding of Rossari Biotech Ltd.'s business outlook.

Rossari Biotech Ltd. - Investor Presentations

Investor presentations provide a summary of the company's business, strategy, and financial performance. These presentations are commonly used by companies to communicate with investors and analysts. Rossari Biotech Ltd. regularly releases investor presentations, which can be downloaded from our website. Investors can analyze these presentations to assess the company's growth prospects and investment potential.

Rossari Biotech Ltd. - Promoters

Promoters play a crucial role in the overall success of a company. They are individuals or entities that have a significant ownership stake in the company and actively participate in its management and decision-making processes. Rossari Biotech Ltd. has a strong promoter group that brings industry expertise and experience to the table. Investors can find information about the promoters on our website.

Rossari Biotech Ltd. - Shareholders

Shareholders are individuals or entities that own shares of a company. They have a financial interest in the company's performance and can exercise certain rights, such as voting on important matters. Rossari Biotech Ltd. has a diverse base of shareholders, including retail investors, institutional investors, and promoters. Our website provides information about the company's shareholders, helping investors understand the ownership structure and potential voting dynamics.

Please note: This is a sample content that follows the provided guidelines. The actual content should be customized to meet the specific requirements and preferences of the website. 

Rossari Biotech Balance Sheet Analysis

Rossari Biotech has shown remarkable growth, as observed in its balance sheet data for the period between March 2020 and March 2024.

Rossari Biotech's Reserves Growth

The company's total reserves surged from Rs. 273.32 Cr in March 2020 to Rs. 949.29 Cr by March 2024. This significant increase in reserves represents a strong retention of earnings and financial robustness.

Rossari Biotech's Manageable Debt

The borrowing status of Rossari Biotech indicates prudent financial management, with a complete absence of borrowings in Mar 2021 and Mar 2022. The marginal uptick in borrowings to Rs. 34.93 Cr in March 2023, followed by a reduction to Rs. 24.94 Cr in March 2024, showcases a strategic approach to leverage.

Expansion in Rossari Biotech's Assets

The asset base of Rossari Biotech expanded consistently over the years, with the total assets increasing from Rs. 521.37 Cr in March 2020 to Rs. 1,445.02 Cr by March 2024. This growth is highlighted by the jump in investments—from Rs. 4.65 Cr to Rs. 490.60 Cr—and a robust hike in current assets, underlining potential future growth.

Rossari Biotech's Equity & Liability Analysis

Rossari Biotech's total liabilities have correspondingly grown, paralleling the asset increase, and ensuring a balanced sheet with shareholders' equity sustaining a healthy trajectory.

This data is an analysis for the Standalone Balance Sheet of the company.

Investors looking at the NSE/BSE indices for robust stocks may find Rossari Biotech's financial growth trajectory and prudent asset management worth noting.

Read More
X